Base salary $500,000 • Stock awards $1. The CEO's pay package is funded by the same company that claims it cannot find qualified American workers for its open positions.
| Executive | Title | Base Salary | Stock Awards | Total Comp |
|---|---|---|---|---|
| Prashant Kohli | Chief Executive Officer | $500,000 | $1 | $1,074,621 |
| Carrie D’Andrea | Vice President, Clinical Operations | $286,000 | $1 | $421,563 |
| Amresh Kumar | Vice President, Program Management | $286,000 | $1 | $421,563 |
SCT = Summary Compensation Table totals from SEC EDGAR DEF 14A proxy statement.
| Director | Role | Age | Independent | Since | Tenure | Annual Pay | Committees |
|---|---|---|---|---|---|---|---|
| Edward Neugeboren | Director | 56 | Yes | N/A | N/A | N/A | |
| Prashant Kohli | Director and Chief Executive Officer | 53 | No | N/A | N/A | N/A | |
| Vimal Kavuru | Director and Chair of the Board | 56 | No | N/A | N/A | N/A |
Source: SEC EDGAR DEF 14A proxy statement via sec-api.io.
Search all Grace Therapeutics, Inc. H-1B Labor Condition Applications filed with the U.S. Dept. of Labor.
🔍 Search H-1B Records for Grace Therapeutics, Inc.Source: U.S. Dept. of Labor OFLC disclosure data. LCA filing does not guarantee a visa was issued.
This analysis is produced independently — one person, 23 years of data work, living on $1,419/month Social Security. If these reports help you understand how H-1B visas affect American workers, a small donation makes a real difference.
♥ Donate via Square More Reports